Brief: Savara Inc- Apap Clearpath, Is Now Available To Physicians In U.S.

Dec 21 (Reuters) - Savara Inc  SVRA.O :
    * SAVARA INC-  APAP CLEARPATH, A NEW SERUM-BASED BLOOD TEST
TO
OBTAIN A DEFINITIVE DIAGNOSIS OF APAP IS NOW AVAILABLE TO
PHYSICIANS IN U.S.
    * SAVARA INC- EXPECTS TO ROLL OUT A HEALTHCARE PROVIDER
DISEASE
AWARENESS CAMPAIGN AND GM-CSF AUTOANTIBODY BLOOD TEST IN EUROPE
NEXT YEAR

Source text for Eikon:  ID:nBwbHgfjBa 
Further company coverage:  SVRA.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Savara

See all news